Fierce Biotech August 21, 2024
Heather Landi

Roche says it’s actively working with its partners to enhance mpox laboratory capacity worldwide to develop diagnostic tests to combat the outbreak.

The World Health Organization (WHO) last week declared mpox, formerly known as monkeypox, a global public health emergency. It’s the second time in two years WHO has sounded the alarm about mpox as a new variant of the disease, known as clade 1b, spread rapidly in Africa.

The Swiss pharmaceutical company said Tuesday it is supporting the international response to the mpox global health emergency with its diagnostic tests developed for the virus. Mpox is a viral disease that can spread easily between people and from infected animals. The company...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Healthcare System, Pharma / Biotech, Public Health / COVID
Pharma Pulse 11/25/24: Deepening Patient Relationships, Menopause May Increase Risk of Asthma & more
Axolotl Biosciences Brings Biotech to the Forefront at Formnext 2024
Innovative approach maps gene activity in the living human brain
Trump tariffs could drive up generic drug costs: 5 takeaways
Answer ALS, Cedars-Sinai Collaboration, Single-Cell Protein Profiling, ChapsVision Acquires Sinequa, More

Share This Article